Vertex Pharmaceuticals Incorporated shares owned by BlackRock
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $10B | 21M | 468.72 |
| 2024-03-31 | $9.2B | 22M | 418.01 |
| 2023-09-30 | $7.9B | 23M | 347.74 |
| 2023-06-30 | $8.0B | 23M | 351.91 |
| 2023-03-31 | $7.5B | 24M | 315.07 |
| 2022-12-31 | $7.0B | 24M | 288.78 |
| 2022-06-30 | $7.1B | 25M | 281.79 |
| 2021-06-30 | $4.7B | 23M | 201.63 |
| 2021-03-31 | $5.2B | 24M | 214.89 |
| 2020-12-31 | $5.7B | 24M | 236.34 |
| 2020-09-30 | $6.9B | 25M | 272.12 |
| 2020-03-31 | $5.3B | 22M | 237.95 |
| 2019-12-31 | $4.6B | 21M | 218.95 |
| 2019-09-30 | $3.6B | 21M | 169.42 |
| 2019-06-30 | $3.8B | 21M | 183.38 |
| 2019-03-31 | $3.7B | 20M | 183.95 |
| 2018-12-31 | $3.2B | 20M | 165.71 |
| 2018-09-30 | $3.8B | 20M | 192.74 |
| 2018-06-30 | $3.3B | 19M | 169.96 |
| 2018-03-31 | $3.2B | 20M | 162.98 |
| 2017-09-30 | $3.0B | 20M | 152.04 |
| 2016-12-31 | $51M | 688k | 73.67 |
| 2016-09-30 | $65M | 747k | 87.21 |
| 2016-06-30 | $64M | 739k | 86.02 |
| 2016-03-31 | $54M | 679k | 79.49 |
| 2015-12-31 | $90M | 713k | 125.83 |
| 2015-09-30 | $72M | 689k | 104.14 |
| 2015-06-30 | $94M | 759k | 123.48 |
| 2015-03-31 | $113M | 954k | 117.97 |
| 2014-12-31 | $104M | 873k | 118.80 |
| 2014-09-30 | $76M | 675k | 112.31 |
| 2014-06-30 | $52M | 548k | 94.68 |
| 2014-03-31 | $44M | 619k | 70.72 |
| 2013-12-31 | $51M | 693k | 74.30 |
| 2013-09-30 | $43M | 562k | 75.82 |
| 2013-06-30 | $11M | 131k | 80.07 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated